Estados financieros detallados de Caribou Biosciences, Inc. (CRBU): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Caribou Biosciences, Inc. registró ingresos de $11.2M en el último ejercicio fiscal, con un CAGR de 5 años del -2.0%.
Márgenes de los últimos 12 meses: margen bruto -129.7%, margen operativo -10.9%, margen neto -10.3%.
Al precio actual de $1.25, CRBU presenta beneficios negativos (P/E no significativo) y un ROE del -89.11%. La capitalización bursátil es de $124M.
Cuenta de Resultados (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $5.8M | $12.4M | $9.6M | $13.9M | $34.5M | $10.0M | $11.2M |
| Coste de Ventas | 0 | $34.4M | $984000 | $3.6M | $3.5M | $3.9M | $3.6M |
| Beneficio Bruto | $5.8M | -$22.1M | $8.6M | $10.2M | $31.0M | $6.1M | $7.5M |
| I+D | $23.6M | $34.4M | $52.3M | $82.2M | $112.1M | $130.2M | $109.4M |
| Generales y Administrativos | $16.5M | $14.1M | $23.3M | $38.0M | $38.5M | $46.5M | $37.9M |
| Gastos Operativos | $40.1M | $14.1M | $75.6M | $116.6M | $147.0M | $172.7M | $143.7M |
| Beneficio Operativo | -$34.3M | -$36.1M | -$67.0M | -$106.4M | -$116.1M | -$166.6M | -$136.2M |
| EBITDA | -$30.2M | -$35.2M | -$65.6M | -$95.7M | -$98.4M | -$145.2M | -$145.0M |
| Gastos por Intereses | $4000 | $20000 | $8000 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$31.0M | -$36.1M | -$66.6M | -$99.4M | -$101.9M | -$149.1M | -$148.7M |
| Impuestos | -$7.5M | -$1.8M | $321000 | $70000 | $193000 | -$9000 | -$550000 |
| Beneficio Neto | -$23.4M | -$34.3M | -$66.9M | -$99.4M | -$102.1M | -$149.1M | -$148.1M |
| BPA | $-0.85 | $-1.24 | $-1.11 | $-1.64 | $-1.38 | $-1.65 | $-1.59 |
| BPA Diluido | $-0.85 | $-1.24 | $-1.11 | $-1.64 | $-1.38 | $-1.65 | $-1.59 |
| Acciones en Circulación (Diluidas) | $27.7M | $27.7M | $60.3M | $60.8M | $73.8M | $90.3M | $93.4M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $2.2M | $3.9M | $2.4M | $1.5M |
| Beneficio Bruto | -$20.2M | $3.9M | $1.7M | $1.5M |
| Beneficio Operativo | -$29.4M | -$28.5M | -$26.3M | -$25.3M |
| EBITDA | -$26.9M | -$26.4M | -$24.4M | -$26.4M |
| Beneficio Neto | -$27.5M | -$26.5M | -$25.1M | -$24.3M |
| BPA | $-0.30 | $-0.28 | $-0.26 | $-0.24 |
| BPA Diluido | $-0.30 | $-0.28 | $-0.26 | $-0.24 |
Balance (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $41.1M | $16.0M | $240.4M | $58.3M | $51.2M | $16.3M | $12.4M |
| Inversiones a Corto | $8.4M | 0 | $135.4M | $189.3M | $277.7M | $193.2M | $127.0M |
| Cuentas por Cobrar | $4.0M | $5.2M | $8.1M | $4.7M | $3.9M | $3.3M | $3.0M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $57.0M | $24.3M | $391.2M | $260.2M | $338.8M | $219.4M | $145.2M |
| Inmovilizado Material | $4.3M | $3.5M | $4.9M | $34.9M | $40.5M | $39.3M | $24.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $61.9M | $36.0M | $442.4M | $373.8M | $432.2M | $313.3M | $175.4M |
| Cuentas por Pagar | $2.5M | $2.6M | $4.0M | $1.1M | $3.1M | $2.5M | $5.8M |
| Deuda a Corto | $532000 | $654000 | $259000 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $10.1M | $12.4M | $25.8M | $28.1M | $28.3M | $30.7M | $25.4M |
| Deuda a Largo | 0 | $924000 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $54.5M | $59.5M | $54.5M | $72.9M | $63.8M | $60.4M | $53.2M |
| Reservas | $3.4M | -$30.9M | -$97.8M | -$197.2M | -$299.3M | -$448.4M | -$596.5M |
| Patrimonio Neto | $7.5M | -$23.4M | $387.8M | $300.9M | $368.4M | $253.0M | $122.2M |
| Deuda Total | $532000 | $1.6M | $259000 | $27.7M | $27.1M | $26.5M | $27.2M |
| Deuda Neta | -$48.9M | -$14.4M | -$375.6M | -$219.9M | -$301.7M | -$183.1M | -$112.1M |
| Capital Circulante | $46.9M | $11.9M | $365.4M | $232.1M | $310.5M | $188.7M | $119.8M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $11.1M | $12.4M | $12.1M | $26.2M |
| Activos Totales | $195.0M | $179.6M | $149.0M | $142.8M |
| Pasivos Totales | $53.1M | $57.5M | $47.0M | $44.7M |
| Patrimonio Neto | $141.8M | $122.2M | $102.0M | $98.1M |
| Deuda Total | $25.5M | $27.2M | $26.9M | $26.7M |
Flujo de Caja (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$23.4M | -$34.3M | -$66.9M | -$99.4M | -$102.1M | -$149.1M | -$148.1M |
| Amortizaciones | $751000 | $900000 | $984000 | $1.6M | $3.5M | $3.9M | $3.6M |
| Compensación en Acciones | $1.2M | $1.0M | $3.4M | $11.7M | $13.8M | $16.7M | $12.7M |
| Cambio en Capital Circulante | -$8.3M | $177000 | $29.1M | -$4.2M | -$7.3M | -$5.1M | -$484000 |
| Flujo de Caja Operativo | -$32.0M | -$33.2M | -$32.5M | -$91.0M | -$93.3M | -$138.2M | -$111.0M |
| Inversiones (CapEx) | -$884000 | -$1.3M | -$3.1M | -$7.1M | -$11.6M | -$6.5M | -$1.4M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$32.9M | -$34.5M | -$35.6M | -$98.0M | -$104.9M | -$144.7M | -$112.4M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$25.2M | -$20.8M | -$27.0M | -$22.8M |
| Inversiones (CapEx) | -$115000 | $216000 | -$72000 | -$1000 |
| Flujo de Caja Libre | -$25.3M | -$20.6M | -$27.1M | -$22.8M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $2.9M | $2.7M | $2.4M | $2.5M |
Crecimiento y Márgenes (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +113.6% | -22.4% | +44.3% | +148.9% | -71.0% | +11.7% |
| Crecimiento Beneficio Neto (anual) | | -46.4% | -95.1% | -48.6% | -2.7% | -46.1% | +0.7% |
| Crecimiento BPA (anual) | | -45.9% | +10.5% | -47.7% | +15.9% | -19.6% | +3.6% |
| Cambio en Acciones (anual) | | +0.0% | +117.9% | +0.9% | +21.4% | +22.4% | +3.4% |
| Crecimiento FCF (anual) | | -5.0% | -3.2% | -175.0% | -7.0% | -37.9% | +22.4% |
| Margen Bruto | 100.0% | -178.5% | 89.7% | 73.7% | 89.8% | 60.7% | 67.3% |
| Margen Operativo | -592.7% | -292.2% | -697.8% | -768.2% | -336.6% | -1667.2% | -1220.5% |
| Margen EBITDA | -522.0% | -284.8% | -683.6% | -691.0% | -285.3% | -1452.7% | -1299.7% |
| Margen Neto | -404.8% | -277.6% | -697.3% | -717.8% | -296.1% | -1491.9% | -1327.4% |
| Margen FCF | -568.2% | -279.3% | -371.3% | -707.7% | -304.3% | -1447.9% | -1006.8% |
| Tasa Impositiva Efectiva | 24.3% | 5.0% | -0.5% | -0.1% | -0.2% | 0.0% | 0.4% |
Datos por Acción (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-1.19 | $-1.25 | $-0.59 | $-1.61 | $-1.42 | $-1.60 | $-1.20 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $27.7M | $27.7M | $60.3M | $60.8M | $73.8M | $90.3M | $93.4M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -89.11% |
| Rentabilidad sobre capital invertido | -86.30% |
| Rentabilidad sobre activos | -72.42% |
| Margen bruto | -129.70% |
| Margen operativo | -1090.90% |
| Margen neto | -1030.42% |
Salud financiera
| Deuda / Patrimonio | 0.27 |
| Ratio corriente | 6.49 |
Ratios Clave (10 años)
| Año | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -19.20 | -13.16 | -13.59 | -3.83 | -4.15 | -0.96 | -1.00 |
| P/VC | 60.48 | -19.26 | 2.34 | 1.27 | 1.15 | 0.57 | 1.22 |
| P/V | 77.98 | 36.52 | 94.75 | 27.57 | 12.27 | 14.37 | 13.31 |
| Margen Bruto | 100.0% | -178.5% | 89.7% | 73.7% | 89.8% | 60.7% | 67.3% |
| Margen Operativo | -592.7% | -292.2% | -697.8% | -768.2% | -336.6% | -1667.2% | -1220.5% |
| Margen Neto | -404.8% | -277.6% | -697.3% | -717.8% | -296.1% | -1491.9% | -1327.4% |